» Articles » PMID: 33573266

SSnet: A Deep Learning Approach for Protein-Ligand Interaction Prediction

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2021 Feb 12
PMID 33573266
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Computational prediction of Protein-Ligand Interaction (PLI) is an important step in the modern drug discovery pipeline as it mitigates the cost, time, and resources required to screen novel therapeutics. Deep Neural Networks (DNN) have recently shown excellent performance in PLI prediction. However, the performance is highly dependent on protein and ligand features utilized for the DNN model. Moreover, in current models, the deciphering of how protein features determine the underlying principles that govern PLI is not trivial. In this work, we developed a DNN framework named SSnet that utilizes secondary structure information of proteins extracted as the curvature and torsion of the protein backbone to predict PLI. We demonstrate the performance of SSnet by comparing against a variety of currently popular machine and non-Machine Learning (ML) models using various metrics. We visualize the intermediate layers of SSnet to show a potential latent space for proteins, in particular to extract structural elements in a protein that the model finds influential for ligand binding, which is one of the key features of SSnet. We observed in our study that SSnet learns information about locations in a protein where a ligand can bind, including binding sites, allosteric sites and cryptic sites, regardless of the conformation used. We further observed that SSnet is not biased to any specific molecular interaction and extracts the protein fold information critical for PLI prediction. Our work forms an important gateway to the general exploration of secondary structure-based Deep Learning (DL), which is not just confined to protein-ligand interactions, and as such will have a large impact on protein research, while being readily accessible for de novo drug designers as a standalone package.

Citing Articles

The changing scenario of drug discovery using AI to deep learning: Recent advancement, success stories, collaborations, and challenges.

Chakraborty C, Bhattacharya M, Lee S, Wen Z, Lo Y Mol Ther Nucleic Acids. 2024; 35(3):102295.

PMID: 39257717 PMC: 11386122. DOI: 10.1016/j.omtn.2024.102295.


Structure-based protein and small molecule generation using EGNN and diffusion models: A comprehensive review.

Soleymani F, Paquet E, Viktor H, Michalowski W Comput Struct Biotechnol J. 2024; 23:2779-2797.

PMID: 39050782 PMC: 11268121. DOI: 10.1016/j.csbj.2024.06.021.


Melodia: A Python Library for Protein Structure Analysis.

Montalvao R, Pitt W, Pinheiro V, Blundell T Bioinformatics. 2024; .

PMID: 39037932 PMC: 11290362. DOI: 10.1093/bioinformatics/btae468.


Diffusion models in bioinformatics and computational biology.

Guo Z, Liu J, Wang Y, Chen M, Wang D, Xu D Nat Rev Bioeng. 2024; 2(2):136-154.

PMID: 38576453 PMC: 10994218. DOI: 10.1038/s44222-023-00114-9.


A comparison of embedding aggregation strategies in drug-target interaction prediction.

Iliadis D, De Baets B, Pahikkala T, Waegeman W BMC Bioinformatics. 2024; 25(1):59.

PMID: 38321386 PMC: 10845509. DOI: 10.1186/s12859-024-05684-y.


References
1.
Triballeau N, Acher F, Brabet I, Pin J, Bertrand H . Virtual screening workflow development guided by the "receiver operating characteristic" curve approach. Application to high-throughput docking on metabotropic glutamate receptor subtype 4. J Med Chem. 2005; 48(7):2534-47. DOI: 10.1021/jm049092j. View

2.
Le N, Do D, Hung T, Lam L, Huynh T, Nguyen N . A Computational Framework Based on Ensemble Deep Neural Networks for Essential Genes Identification. Int J Mol Sci. 2020; 21(23). PMC: 7730808. DOI: 10.3390/ijms21239070. View

3.
Bleakley K, Yamanishi Y . Supervised prediction of drug-target interactions using bipartite local models. Bioinformatics. 2009; 25(18):2397-403. PMC: 2735674. DOI: 10.1093/bioinformatics/btp433. View

4.
Patil R, Das S, Stanley A, Yadav L, Sudhakar A, Varma A . Optimized hydrophobic interactions and hydrogen bonding at the target-ligand interface leads the pathways of drug-designing. PLoS One. 2010; 5(8):e12029. PMC: 2922327. DOI: 10.1371/journal.pone.0012029. View

5.
Sieg J, Flachsenberg F, Rarey M . In Need of Bias Control: Evaluating Chemical Data for Machine Learning in Structure-Based Virtual Screening. J Chem Inf Model. 2019; 59(3):947-961. DOI: 10.1021/acs.jcim.8b00712. View